Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 294-571-5 | CAS number: 91744-09-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- migrated information: read-across based on grouping of substances (category approach)
- Adequacy of study:
- weight of evidence
- Study period:
- 27 Nov 1984 -20 Dec 1984
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: GLP-Guideline study with acceptable restrictions. Lack of test material details. Only the highest dose group was evaluated.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 985
- Report date:
- 1985
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- yes
- Remarks:
- lack of test material details; only the highest dose group was evaluated
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- Glycerides, C16-18 and C18-hydroxy mono- and di-
- EC Number:
- 295-191-2
- EC Name:
- Glycerides, C16-18 and C18-hydroxy mono- and di-
- Cas Number:
- 91845-19-1
- IUPAC Name:
- 91845-19-1
- Details on test material:
- - Name of test material (as cited in study report): only trade name given
- Chemical denomination: Glyceride, C16-18 und C18 mono- und dihydroxyfettsäuren
- Physical state: white solid
- Analytical purity: no data
- Analytical data: melting point: 94 °C; acid value: 1.0; saponification value: 178; hydroxyl value: 138; iodine value: 3.4; epoxy oxygen content: 0.4%
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- other: CFW 1 (Winkelmann)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Winkelmann, Borchen, Germany
- Age at study initiation: 8 weeks
- Weight at study initiation: 21-29 g
- Fasting period before study: animals were fasted at least 4 h prior to administration.
- Housing: male animals were housed individually in Makrolon cages type I, female animals were housed in groups up to 4 animals in Makrolon cages type II
- Diet: Haltungsdiät Altromin 1324, 10 mm pellets (Altrogge Spezialfutter), feeding frequency not further specified
- Water: tap water, ad libitum
ENVIRONMENTAL CONDITIONS
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: peanut oil Oleum Arachidis G166/DAB 8
- Amount of vehicle: 20 mL/kg bw - Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
An aliquot of the test substance was molten at 70 ºC and mixed with 70 ºC warm peanut oil. After cooling of the solution, the mixture was applicated by oral gavage.
- Duration of treatment / exposure:
- single application
- Frequency of treatment:
- single application
- Post exposure period:
- 24, 48 and 72 h after treatment
Doses / concentrations
- Remarks:
- Doses / Concentrations:
1000, 5000 and 10000 mg/kg bw
Basis:
actual ingested
- No. of animals per sex per dose:
- Preliminary study: 2
Main study: 7 - Control animals:
- yes, concurrent vehicle
- Positive control(s):
- - Cyclophosphamide
- Route of administration: intraperitoneal injection
- Doses / concentrations: 10 mg/kg bw in water
Examinations
- Tissues and cell types examined:
- Tissue: femoral bone marrow
Cell type: erythrocytes of the bone marrow - Details of tissue and slide preparation:
- DETAILS OF SLIDE PREPARATION:
Slides were fixed with methanol and stained with Giemsa-solution for 10 min.
METHOD OF ANALYSIS: 1 slide per animal was analysed. The number of micronuclei was counted in 1000 polychromatic erythrocytes per animal and the ratio of polychromatic and normochromatic erythrocytes was recorded.
- Statistics:
- Mean values and standard deviations were calculated. For calculation of significances the tables of Kastenbaum and Bowman (Kastenbaum, M.A. and Bowman, K.O., 1970, Mutation Research 9:527-549) were used.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Remarks:
- Animals of all dose groups showed reduced activity and ruffled fur.
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
- Dose range: 5000, 7500 and 10000 mg/kg bw
- Clinical signs of toxicity in test animals: In the mid dose-group slightly reduced activity and ruffled fur was observed up to 20 h after application. In the high dose-group all animals showed slightly reduced activity, in male animals strongly ruffled fur and in female animals slightly ruffled fur was observed. No clinical signs of systemic toxicity were observed after 48 h.
RESULTS OF DEFINITIVE STUDY
- Induction of micronuclei: no significant increase of micronuclei number was observed
- Ratio of PCE/NCE: no influence of the test material was observed in comparison to the controls
- Clinical signs of toxicity in test animals: In the low dose-group slightly reduced activity after application was observed and in the mid dose-group slightly reduced activity and ruffled fur was observed after application. No clinical signs of toxicity were observed after 24 h. In the high dose-group all animals showed slightly reduced activity and strongly ruffled fur. No clinical signs of systemic toxicity were observed after 20 h.
Any other information on results incl. tables
No deaths occured during the study. As there were no indications for genotoxicity in animals dosed with 10000 mg/kg bw, analysis of micronuclei was not performed in animals dosed with 1000 and 5000 mg/kg bw.
Table 1: Results of the in vivo micronucleus assay in male animals
Exp group |
Number of animals |
Sampling time (h after administration) |
Dose [mg/kg bw] |
Mean PCEs/NCEs at sampling time |
Total micronuclei per 1000 PCEs at sampling time |
|
mean values |
range |
|||||
Vehicle control (peanut oil) |
7 |
24 |
20 mL/kg |
1.11 |
1.57 |
0-2 |
Positive control (cyclophosphamide) |
7 |
24 |
10 |
1.10 |
7.71 |
4-11 |
Test substance |
7 |
24 |
10000 |
1.20 |
2.14 |
1-4 |
Test substance |
7 |
48 |
10000 |
1.00 |
1.00 |
0-2 |
Test substance |
7 |
72 |
10000 |
1.25 |
1.43 |
0-3 |
Table 2: Results of the in vivo micronucleus assay in female animals
Exp group |
Number of animals |
Sampling time (h after administration) |
Dose [mg/kg bw] |
Mean PCEs/NCEs at sampling time |
Total micronuclei per 1000 PCEs at sampling time |
|
mean values |
range |
|||||
Vehicle control (peanut oil) |
7 |
24 |
20 mL/kg |
1.26 |
1.14 |
0-3 |
Positive control (Cyclophosphamide) |
7 |
24 |
10 |
1.15 |
6.86 |
4-10 |
Test substance |
7 |
24 |
10000 |
1.07 |
2.00 |
1-4 |
Test substance |
7 |
48 |
10000 |
1.06 |
2.29 |
0-6 |
Test substance |
7 |
72 |
10000 |
1.15 |
1.86 |
0-3 |
PCE = polychromatic erythrocytes
NCE = norchromatic erythrocytes
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.